Patents by Inventor Eva M. Horak

Eva M. Horak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bispecific single chain Fv antibody molecules and methods of use therof
    Patent number: 8980258
    Abstract: Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: March 17, 2015
    Assignees: The Regents of the University of California, Fox Chase Cancer Center
    Inventors: Gregory P Adams, Eva M. Horak, Louis M. Weiner, James D. Marks
  • Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof
    Patent number: 8580263
    Abstract: Anti-EGFR family member antibodies and bispecific antibodies comprising one or more anti-EGFR family member antibodies are disclosed. These antibodies can be used to advantage to specifically target forms of cancer associated with the overexpression of members of the EGFR protein family.
    Type: Grant
    Filed: November 20, 2007
    Date of Patent: November 12, 2013
    Assignees: The Regents of the University of California, Fox Chase Cancer Center
    Inventors: Gregory P. Adams, Eva M. Horak, Louis M. Weiner, James D. Marks
  • Bispecific single chain Fv antibody molecules and methods of use thereof
    Patent number: 8329873
    Abstract: Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.
    Type: Grant
    Filed: November 20, 2007
    Date of Patent: December 11, 2012
    Assignees: The Regents of the University of California, Fox Chase Cancer Center
    Inventors: Gregory P. Adams, Eva M. Horak, Louis M. Weiner, James D. Marks
  • ANTI-EGFR FAMILY ANTIBODIES, BISPECIFIC ANTI-EGFR FAMILY ANTIBODIES AND METHODS OF USE THEREOF
    Publication number: 20100196265
    Abstract: Anti-EGFR family member antibodies and bispecific antibodies comprising one or more anti-EGFR family member antibodies are disclosed. These antibodies can be used to advantage to specifically target forms of cancer associated with the overexpression of members of the EGFR protein family.
    Type: Application
    Filed: November 20, 2007
    Publication date: August 5, 2010
    Inventors: Gregory P. Adams, Eva M. Horak, Louis M. Weiner, James D. Marks
  • BISPECIFIC SINGLE CHAIN Fv ANTIBODY MOLECULES AND METHODS OF USE THEREOF
    Publication number: 20090010840
    Abstract: Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.
    Type: Application
    Filed: November 20, 2007
    Publication date: January 8, 2009
    Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Gregory P. Adams, Eva M. Horak, Louis M. Weiner, James D. Marks
  • Bispecific single chain Fv antibody molecules and methods of use thereof
    Patent number: 7332585
    Abstract: Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: February 19, 2008
    Assignees: The Regents of the California University, Fox Chase Cancer Center
    Inventors: Gregory P. Adams, Eva M. Horak, Louis M. Weiner, James D. Marks
  • Bispecific single chain Fv antibody molecules and methods of use thereof
    Patent number: 7332580
    Abstract: Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: February 19, 2008
    Assignees: The Regents of the University of California, Fox Chase Cancer Center
    Inventors: Gregory P. Adams, Eva M. Horak, Louis M. Weiner, James D. Marks
  • Bispecific single chain Fv antibody molecules and methods of use thereof
    Publication number: 20040071696
    Abstract: Bispecific single chain antibody molecules are disclosed which may be used to advantage to treat various forms of cancer associated with the overexpression of members of the EGFR protein family.
    Type: Application
    Filed: April 4, 2003
    Publication date: April 15, 2004
    Applicants: The Regents of the University of California, The Fox Chase Cancer Center
    Inventors: Gregory P. Adams, Eva M. Horak, Louis M. Weiner, James D. Marks